journal article·2010-05-05

Structure−Stability Relationships in Cocrystal Hydrates: Does the Promiscuity of Water Make Crystalline Hydrates the Nemesis of Crystal Engineering?

Heather D. Clarke, Kapildev K. Arora, Heather Bass, Padmini Kavuru, Tien Teng Ong, Twarita Pujari, Lukasz Wojtas, Michael J. Zaworotko

Crystal Growth & Design· Volume 10· Issue 5
Publisher page

Abstract

This contribution addresses the role of water molecules in crystal engineering by studying the crystal structures and thermal stabilities of 11 new cocrystal hydrates, all of which were characterized by single crystal X-ray crystallography, powder X-ray diffraction (PXRD), infrared spectroscopy (IR), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). The cocrystal hydrates can be grouped into four categories based upon thermal stability: (1) water is lost at <100 °C; (2) water is lost between 100 and 120 °C; (3) water is lost at >120 °C; (4) dehydration occurs concurrently with the melt of the cocrystal. In order to address if there is any correlation between structure and stability, the following factors were considered: type of hydrate (tunnel hydrate or isolated hydrate); number of hydrogen bond donors and acceptors; hydrogen bond distances; packing efficiency. Category 1 hydrates exhibit water molecules in tunnels. However, no structure/stability correlations exist in any of the other categories of hydrate. To complement the cocrystal hydrates reported herein, a Cambridge Structural Database (CSD) analysis was conducted in order to address the supramolecular heterosynthons that water molecules exhibit with two of the most relevant functional groups in the context of active pharmaceutical ingredients, carboxylic acids, and alcohols. The CSD analysis suggests that, unlike cocrystals, there is great diversity in the supramolecular heterosynthons exhibited by water molecules when they form hydrogen bonds with carboxylic acids or alcohols. It can therefore be concluded that the promiscuity of water molecules in terms of their supramolecular synthons and their unpredictable thermal stability makes them a special challenge in the context of crystal engineering.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Methane Hydrates and Related Phenomena · Crystallization and Solubility Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, University of South Florida, CHE205, 4202 East Fowler Avenue, Tampa, Florida 33620

References (77)

Show source-provided references
1. Pepinsky R. · Phys. Rev. · 1955 · 100 · 971
2. Schmidt G. M. J. · Pure Appl. Chem. · 1971 · 27 · 64710.1351/pac197127040647 ↗
3. Desiraju G. R. · 1989
4. Etter M. C. · J. Am. Chem. Soc. · 1982 · 104 · 109510.1021/ja00368a031 ↗
5. Moulton B. · J. Chem. Rev. · 2001 · 101 · 162910.1021/cr9900432 ↗
6. Zaworotko M. J. · Cryst. Growth Des. · 2007 · 7 · 410.1021/cg0680172 ↗
7. Vippagunta S. R. · Adv. Drug Delivery Rev. · 2001 · 48 · 310.1016/S0169-409X(01)00097-7 ↗
8. Noyes A. A. · J. Am. Chem. Soc. · 1897 · 19 · 93010.1021/ja02086a003 ↗
9. Amidon G. L. · Pharm. Res. · 1995 · 12 · 41310.1023/A:1016212804288 ↗
10. Vishweshwar P. · J. Pharm. Sci. · 2006 · 95 · 49910.1002/jps.20578 ↗
11. Mol. Pharmaceutics · 2007 · 4 · 29910.1021/mp070042v ↗
12. Shan N. · Drug. Discov. Today · 2008 · 13 · 44010.1016/j.drudis.2008.03.004 ↗
13. Meanwell N. A. · Annu. Rep. Med. Chem. · 2008 · 43 · 373
14. Schultheiss N · Cryst. Growth Des. · 2009 · 9 · 295010.1021/cg900129f ↗
15. Stanton M. K. · Cryst. Growth Des. · 2008 · 8 · 385610.1021/cg800173d ↗
16. Stahly G. P. · Cryst. Growth Des. · 2009 · 9 · 421210.1021/cg900873t ↗
17. Aakeröy C. B. · CrystEngComm · 2008 · 10 · 181610.1039/b811809d ↗
18. Childs S. L. · J. Am. Chem. Soc. · 2004 · 126 · 1333510.1021/ja048114o ↗
19. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
20. Hickey M. B. · Eur. J. Pharm. Biopharm. · 2007 · 67 · 11210.1016/j.ejpb.2006.12.016 ↗
21. Walsh R. D. B. · Chem. Commun. · 2003 · 18610.1039/b208574g ↗
22. Almarsson O. · Chem. Commun. · 2004 · 188910.1039/b402150a ↗
23. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
24. Variankaval N. · Cryst. Growth Des. · 2006 · 6 · 69010.1021/cg050462u ↗
25. Gillon A. L. · Cryst. Growth Des. · 2003 · 3 · 66310.1021/cg034088e ↗
26. Desiraju R. G. · J. Chem. Soc., Chem. Commun. · 1991 · 42610.1039/c39910000426 ↗
27. aStahl, H. P.InTowards Better Safety of Drugs and Pharmaceutical Products;Braimar, D. D., Ed.Biomedical Press:Elsevier North Holland, 1980; pp265−280.
28. Jeffrey G. A. · 1997
29. Bettinetti G. · J. Pharm. Sci. · 1999 · 88 · 113310.1021/js990150b ↗
30. Stephenson G. A. · J. Pharm. Sci. · 1998 · 87 · 53610.1021/js970449z ↗
31. Khankari R. K. · Int. J. Pharm. · 1992 · 82 · 11710.1016/0378-5173(92)90080-L ↗
32. Chen L. R. · J. Pharm. Sci. · 1999 · 88 · 119110.1021/js9900710 ↗
33. Apperly D. C. · J. Pharm. Sci. · 2005 · 94 · 51610.1002/jps.20271 ↗
34. bZegarac, M.; Mestrovic, E.; Dumbovic, A.; Devcic, M.; Tudja, P.WO 2007/080362 A1.
35. Henck J. O. · Pharm. Ind. · 1997 · 59 · 165
36. Allen F. H. · Chem. Des. Automat. News · 1993 · 8 · 31
37. Allen F. H. · Acta Crystallogr. · 2002 · 58 · 38010.1107/S0108768102003890 ↗
38. Infantes L. · CrystEngComm · 2007 · 9 · 6510.1039/B612529H ↗
39. Khankari R. K. · Thermochim. Acta · 1995 · 248 · 6110.1016/0040-6031(94)01952-D ↗
40. bMorris, K. R.Polymorphism in Pharmaceutical Solids;Brittain, H. G., Ed.Marcel Dekker, Inc.:New York, 1999; Vol.95, pp125−181.
41. Infantes L. · CrystEngComm · 2003 · 5 · 48010.1039/b312846f ↗
42. Hickey M. B. · J. Pharm. Sci. · 2007 · 96 · 109010.1002/jps.20919 ↗
43. Kiang Y.-H. · Cryst. Growth Des. · 2009 · 9 · 183310.1021/cg801004a ↗
44. Bak A. · Am. Pharm Rev. · 2008
45. aFalk, M.; Knop, O.Water: A Comprehensive Treatise;Franks, F., Ed.Plenum Press:New York, 1973; Vol.2, pp55−113.
46. Authelin J. R. · Int. J. Pharm. · 2005 · 303 · 3710.1016/j.ijpharm.2005.07.007 ↗
47. Morris, K. R.; Rodriguez-Hornedo, N.Encyclopedia of Pharmaceutical Technology;Swarbrick, J.; Boylan, J., Eds;Marcel Dekker, Inc:New York, 1993; Vol.7, pp393−440.
48. Byrn S. R. · J. Am. Chem. Soc. · 1976 · 98 · 400410.1021/ja00429a048 ↗
49. Reutzel-Edens S. M. · Cryst. Growth Des. · 2003 · 3 · 89710.1021/cg034055z ↗
50. bBritain, H. G.; Morris, K. G.; Boerrigter, S. X. M.Polymorphism in Pharmaceutical Solids;Brittain, H. G., Ed.Informa Healthcare, Inc.:New York, 2009; Vol.192, pp233−279.
51. 2001
52. 2008
53. 2008
54. Sheldrick G. M. · 1996
55. Sheldrick G. M. · 2000
56. Farrugia L. · J. Appl. Crystallogr. · 1999 · 32 · 83710.1107/S0021889899006020 ↗
57. Sheldrick G. M. · Acta Crystallogr. · 2008 · 64 · 11210.1107/S0108767307043930 ↗
58. Sheldrick G. M. · Acta Crystallogr. · 1990 · 46 · 46710.1107/S0108767390000277 ↗
59. Fleischman S. G. · Cryst. Growth Des. · 2003 · 3 · 90910.1021/cg034035x ↗
60. Aakeröy C. B. · Angew. Chem., Int. Ed. · 2001 · 40 · 324010.1002/1521-3773(20010903)40:17<3240::AID-ANIE3240>3.0.CO;2-X ↗
61. Reddy L. S. · Cryst. Growth Des. · 2004 · 4 · 8910.1021/cg034106s ↗
62. Aakeröy C. B. · Chem. Commun. · 2006 · 13 · 144510.1039/b517118k ↗
63. Vishweshwar P. · Cryst. Growth Des. · 2003 · 3 · 78310.1021/cg034037h ↗
64. Videnova-Adrabinska V. · J. Chem. Crystallogr. · 1995 · 25 · 82310.1007/BF01671077 ↗
65. Leiserowitz L. · Acta Crystallogr., Sect. B: Struct. Sci. · 1977 · 33 · 271910.1107/S0567740877009376 ↗
66. Bis J. A. · Mol. Pharmaceutics · 2007 · 4 · 40110.1021/mp070012s ↗
67. Vishweshwar P. · CrystEngComm · 2003 · 5 · 16410.1039/B304078J ↗
68. Papaefstathiou G. S. · Org. Lett. · 2001 · 3 · 383510.1021/ol0165948 ↗
69. McMahon J. A. · Z. Kristallogr. · 2005 · 220 · 34010.1524/zkri.220.4.340.61624 ↗
70. Jagadeesh Babu N. · Mol. Pharmaceutics · 2007 · 4 · 41710.1021/mp070014c ↗
71. Leiserowitz L. · Proc. R. Soc. London Series A · 1983 · 388 · 13310.1098/rspa.1983.0076 ↗
72. Shattock T. R. · Cryst. Growth Des. · 2008 · 8 · 453310.1021/cg800565a ↗
73. Aakeröy C. B. · J. Am. Chem. Soc. · 2002 · 124 · 1442510.1021/ja027845q ↗
74. Vishweshwar P. · J. Org. Chem. · 2002 · 67 · 55610.1021/jo0162484 ↗
75. Kavuru P. · Cryst. Growth Des.
76. Infantes L. · CrystEngComm · 2002 · 4 · 45410.1039/b204934a ↗
77. Spek A. L. · 1997